Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 8/20 | 0.63 |
| ▸ | DRD2 | P14416 | 3/20 | 0.63 |
| ▸ | TLR4 | O00206 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.63 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.63 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.63 |
| ▸ | MLNR | O43193 | 1/20 | 0.63 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.63 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.63 |
| ▸ | APP | P05067 | 1/20 | 0.63 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5674942 | 0.87 | ADRB2 (0.58) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL8587280 | 0.87 | ADRB2 (0.54) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL3710263 | 0.86 | ADRB2 (0.57) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL3388893 | 0.86 | ADRB2 (0.57) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL6507182 | 0.85 | ADRB2 (0.54) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL15874588 | 0.81 | ADRB2 (0.72) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL4457452 | 0.79 | ADRB2 (0.53) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL4436284 | 0.79 | ADRB2 (0.55) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL4608341 | 0.78 | ADRB2 (0.53) | ADRB2DRD2TLR4MAPTDNM1 | |
| SCHEMBL4605047 | 0.78 | ADRB2 (0.45) | ADRB2DRD2TLR4MAPTDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022117893-A2 | COMBINATION THERAPY FOR PATIENTS HAVING ACUTE AND/OR PERSISTENT DYSPNEA | S-FORM PHARMA (BE) | 2022-06-09 | — | — | WO | claimed |
| EP-2970900-A1 | COMPOUNDS FOR INDUCING PROLIFERATION AND DIFFERENTIATION OF CELLS, AND METHODS OF USE THEREOF | The Broad Institute, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014144125-A1 | COMPOUNDS FOR INDUCING PROLIFERATION AND DIFFERENTIATION OF CELLS, AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| WO-2004113296-A1 | A PROCESS FOR PREPARATION OF 1-[9H-CARBAZOL-4-YLOXY]- 3-[{2-(2-(-(METHOXY)PHENOXY)-ETHYL}-AMINO]-PROPAN-2-OL | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2004-12-29 | — | — | WO | claimed |
| EP-1355880-A2 | PROCESS FOR THE PREPARATION OF HETEROCYCLIC INDENE ANALOGS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-10-29 | — | — | EP | claimed |
| WO-2002059089-A2 | PROCESS FOR THE PREPARATION OF HETEROCYCLIC INDENE ANALOGS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-08-01 | — | — | WO | claimed |
| WO-1998038986-A2 | USE OF CARVEDILOL OR DERIVATIVES THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS | ROCHE DIAGNOSTICS GMBH (DE) | 1998-09-11 | — | — | WO | claimed |
| EP-4309673-A2 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE | Bausch Health Ireland Limited (IE) | 2024-01-24 | — | — | EP | disclosed |
| EP-3708179-B1 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE | BAUSCH HEALTH IRELAND LTD (IE) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022117893-A2 | COMBINATION THERAPY FOR PATIENTS HAVING ACUTE AND/OR PERSISTENT DYSPNEA | S-FORM PHARMA (BE) | 2022-06-09 | — | — | WO | disclosed |
| EP-3989971-A1 | NOVEL ANTIVIRAL THERAPIES | Niklovir AB (SE) | 2022-05-04 | — | — | EP | disclosed |
| WO-2020263151-A1 | NOVEL ANTIVIRAL THERAPIES | NIKLOVIR AB (SE) | 2020-12-30 | — | — | WO | disclosed |
| US-20200283480-A1 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | BAUSCH HEALTH COMPANIES INC. (CA) | 2020-09-10 | — | — | US | disclosed |
| EP-0741567-A1 | INHIBITION OF SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXY CARBAZOLE COMPOUNDS | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION-SMITHKLINE BEECHAM CORPORATION LIMITED PARTNERSHIP NO. 1 (US) | 1996-11-13 | — | — | EP | disclosed |
| EP-0671913-A4 | — | — | 1995-10-25 | — | — | EP | disclosed |
| EP-0671913-A1 | ANTIOXYDANT CARDIOPROTECTIVE USE OF, AND METHOD OF TREATMENT USING, HYDROXYCARBAZOLE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995014384-A1 | INHIBITION OF SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXY CARBAZOLE COMPOUNDS | BOEHRINGER MANNHEIM PHARMACEUTICALS (US) | 1995-06-01 | — | — | WO | disclosed |
| WO-1994020097-A1 | USE OF, AND METHOD OF TREATMENT USING, CARBAZOLYL-(4)-OXYPROPANOLAMINE COMPOUNDS FOR INHIBITION OF SMOOTH MUSCLE CELL PROLIFERATION | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION-SMITHKLINE BEECHAM CORPORATION LIMITED PARTNERSHIP NO. 1 (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994020096-A1 | METHOD OF EMPLOYING CARBAZOLYL-(4)-OXYPROPANOLAMINE COMPOUNDS FOR INHIBITION OF SMOOTH MUSCLE CELL PROLIFERATION | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION - SMITHKLINE BECKMAN CORPORATION LIMITED (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994012177-A1 | ANTIOXYDANT CARDIOPROTECTIVE USE OF, AND METHOD OF TREATMENT USING, HYDROXYCARBAZOLE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-06-09 | — | — | WO | disclosed |